For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly ...
Jan 12, 2022
0
8
(Medical Xpress) -- In lab studies, researchers at Virginia Commonwealth University Massey Cancer Center have effectively reprogrammed cells of the innate and adaptive immune system to overcome a key cancer defense mechanism ...
Sep 2, 2011
0
0
More than three-quarters of cancer patients have insufficient levels of vitamin D (25-hydroxy-vitamin D) and the lowest levels are associated with more advanced cancer, according to a study presented on October 2, 2011, at ...
Oct 3, 2011
0
0
Six months following molar pregnancies, women who have high (although decreasing) human chorionic gonadotropin (hCG) concentrations can be treated with chemotherapy. A study published Online First by The Lancet shows that ...
Nov 28, 2011
0
0
A smartphone-based self-management app does not reduce the risk of relapse among patients with bipolar disorder, but can reduce relapse risk and manic symptom severity for low-risk individuals, according to a study published ...
Dec 22, 2022
0
44
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, ...
Jun 3, 2012
0
0
(HealthDay)—Psychosocial and psychological interventions are effective for relapse prevention in schizophrenia, according to a review published online Oct. 12 in The Lancet Psychiatry.
Oct 29, 2021
0
3
A new study has revealed detailed information on the various ways patients with multiple sclerosis (MS) become disabled, analyzing both the role of relapses on long-term outcomes and the role of worsening that occurs independent ...
Feb 14, 2022
0
14
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. This is suggested in a paper published by researchers at ...
Feb 21, 2019
0
70
A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms ...
Jul 20, 2011
0
0
